Clinical Trial Update: An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating reduction in facial erythema in adults with moderate to severe persistent rosacea; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema
• Rosacea

Snippet

Sponsor: Padagis LLC | Conditions: Rosacea, Erythema | Phase 3 | Status: COMPLETED | Results posted: 2021-01-05